Despite a promising approach for certain leukemia patients, the path to market appears to be in question.
| less than a minute read
This CD22 Approach Highlights the Importance of Experimental Medicine - and Collaboration
Get in touch
Get in touch
The therapy was developed at the National Cancer Institute, and Dr. Mackall said researchers did not know if a company would try to bring it to market.
Get in touch
Get in touch
Latest Insights
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-09-23-14-44-49-507-6ab3e5e1470f335536fcf89c.jpg)
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-09-22-15-19-50-498-6ab29c96af556e9074387689.jpg)